Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1996
05/02/1996WO1996012490A1 Methods of inhibiting conditions associated with neuropeptide y
05/02/1996WO1996012486A1 Use of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease
05/02/1996WO1996012481A1 Autism remedy
05/02/1996WO1996012472A1 Liposome composition containing selegilin
05/02/1996DE4439492A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
05/02/1996CA2203656A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
05/02/1996CA2203426A1 Heterocyclic compounds and their use
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2203265A1 Production and use of human and plant methyltransferases
05/02/1996CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996CA2203018A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996CA2200990A1 Methods of inhibiting conditions associated with neuropeptide y
05/01/1996EP0709384A1 Benzylpiperidine derivatives having high affinity for binding sites of aminoacid receptors
05/01/1996EP0709381A1 Heterocyclic compounds and their preparation and use
05/01/1996EP0709378A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds
05/01/1996EP0709375A2 Therapeutic heterocycles
05/01/1996EP0709371A1 O-arylmethyl N-(thio)acyl hydroxylamines as ligands for the melatonine receptors, their processes of preparation and the pharmaceutical compositions containing them
05/01/1996EP0709095A2 Method for treating anxiety using a tetrahydropyridine or azabicyclic oxadiazole or thiadiazole compound
05/01/1996EP0709094A2 Method for treating anxiety using a tetrahydropyridine oxadiazole or thiadiazole compound
05/01/1996EP0709093A2 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound
05/01/1996EP0708829A1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
05/01/1996EP0708778A1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists
05/01/1996EP0708777A1 Abeo-ergoline derivatives as 5ht1a ligands
05/01/1996EP0708774A1 Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
05/01/1996EP0708771A1 Benzyloxyquinuclidines as substance p antagonists
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996EP0708641A1 Use of nabumetone or 6-methoxynaphthyl acetic acid for the treatment of dementia
05/01/1996EP0708639A1 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
05/01/1996EP0457883B1 New bicyclic amino-substituted compounds
05/01/1996CN1121720A Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
05/01/1996CN1121719A Risperidone pamoate
05/01/1996CN1121717A Heterocyclic compounds and their preparation and use
05/01/1996CN1121710A Heterocyclic compounds, their use and preparation
05/01/1996CN1121689A Use of indole derivatives as 5HT1 antagonists
05/01/1996CN1121688A Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
05/01/1996CN1031709C Process for preparing new 3,4-dehydropiperidine derivatives and their salt
05/01/1996CA2161618A1 Benzylpiperidine derivatives
04/1996
04/30/1996US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor
04/30/1996US5512590 Prevents disorder of gabaergic transmission
04/30/1996US5512579 Aminobenzoic acid derivatives
04/30/1996US5512578 Administering bimodally-acting opioid agonist and excitatory opioid receptor antagonist
04/30/1996US5512574 Treating neurological and mental illnesses, such as alzheimer's
04/30/1996US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists
04/30/1996US5512569 Aminoalkyl benzothiazolinones
04/30/1996US5512566 Useful in treating diseases of central nervous system
04/30/1996US5512563 Tricyclic benzazepine vasopressin antagonists
04/30/1996US5512562 Tricyclic 2,3,4,5-tetrahydro-1H-3-benzapines
04/30/1996US5512460 Glia activating factor and its production
04/30/1996US5512302 Pharmaceutical process using starch
04/30/1996US5512296 Methods for inhibiting neuronal damage
04/30/1996CA2027783C 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
04/30/1996CA2027782C 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
04/30/1996CA1338302C Therapeutic octapeptide somatostatin analogs
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/29/1996CA2154543A1 Human 26s proteasome subunit components
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996WO1996011948A1 Neurotrophic peptides of activity dependent neurotrophic factor
04/25/1996WO1996011940A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors
04/25/1996WO1996011934A1 Tricyclic spiro compounds process for their preparation and their use as 5ht1d receptor antagonists
04/25/1996WO1996011933A1 Fused pyrrolocarbazoles
04/25/1996WO1996011930A1 Cns-active pyridinylurea derivatives
04/25/1996WO1996011922A1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists
04/25/1996WO1996011914A1 New carboxylic acid derivatives, their preparation and their use
04/25/1996WO1996011902A1 Pharmaceutically active substituted aromatic compounds
04/25/1996WO1996011698A1 Allosteric modulators of the nmda receptor
04/25/1996WO1996011689A1 Use of cck-b receptor antagonists for the treatment of sleep disorders
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/25/1996WO1996011676A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2201527A1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists
04/25/1996CA2161176A1 Heterocyclic compounds and their preparation and use
04/24/1996EP0708102A1 5-HT1F agonists for the treatment of migraine
04/24/1996EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists
04/24/1996EP0708099A1 Tricyclic amide compounds, process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
04/24/1996EP0707587A1 Pharmacologically active enantiomers
04/24/1996EP0707584A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
04/24/1996EP0707579A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists
04/24/1996EP0707577A1 Heme binding compounds and use thereof
04/24/1996EP0707574A1 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives
04/24/1996EP0707573A1 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
04/24/1996EP0707571A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands
04/24/1996EP0707570A1 Isoquinoline derivatives as therapeutic agents
04/24/1996EP0707568A1 N-substituted azaheterocyclic carboxylic acids and esters thereof
04/24/1996EP0707487A1 Methods and pharmaceutical compositions useful for treating neurological disorders
04/24/1996EP0707478A1 Improved nicotine lozenge and therapeutic method for smoking cessation
04/24/1996EP0707477A1 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
04/24/1996EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology
04/24/1996EP0609371B1 Thienopyrazine-2,3-diones useful for treating cns disorders, and their preparation.
04/24/1996EP0573562B1 Dihydroquinoline NMDA antagonists
04/24/1996EP0564658B1 2-(2,3-dicarboxycyclopropyl)glycine and method for producing the same
04/24/1996CN1121349A Heterocyclic compounds and their preparation and use
04/24/1996CN1121348A Indole derivatives as 5-H1-like agonists for use in migraine
04/24/1996CN1121345A New compounds
04/24/1996CN1121344A New compounds
04/24/1996CN1121072A Acetamides
04/24/1996CN1120951A Chinese patent drug Yuxianzaichundan pellet for treatment of epilepsy
1 ... 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 ... 1833